Home › Trial NCT00522392
Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
- Trial IDNCT00522392
- StatusTerminated
- PhasePhase 3
- Study typeInterventional
- SponsorNational Cancer Institute (NCI)
- Enrollment48
- Start date2007-09
- ConditionsStage I Multiple Myeloma · Stage II Multiple Myeloma · Stage III Multiple Myeloma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.